Health, Education & Government Life Sciences & Pharma Implantable Devices

Cardiac Devices

Regulated development and commercialization journeys where clinical, quality, and market access align.

Medtronic Abbott (St. Jude) Boston Scientific Biotronik
Inside this journey
  1. Pre-Discovery

    Align the room on outcomes, decision process, and constraints before deeper discovery.

    1. Stakeholder Alignment

      Confirm decision roles, timeline, procurement constraints, and success criteria across clinical, device clinic, and value analysis stakeholders.

      Alignment Questions

      How You Run Your Device Program — Quick Snapshot

      • Which best describes your role? Options: Electrophysiology (EP) section chief, Device clinic director/manager, Cardiology service line administrator, Cardiac surgeon, Clinic nurse/coordinator, Other
      • What is your typical annual implant volume across all device types? Options: <50, 50–149, 150–299, 300–499, 500+
      • Briefly describe your current device mix and any manufacturers you prefer or avoid.
      • Which stakeholders typically influence device selection at your center? Options: Electrophysiology physicians, Cardiac surgeons, Device clinic director, Procurement/purchasing, Value analysis committee (VA), Radiology/MRI leadership, Hospital administration, Other
      • Tell us about a recent implant-related success or a persistent problem that still nags at your team.

      Are Silent Device Problems Undermining Trust?

      • How often do you suspect device or lead reliability concerns cause you to change practice without formally documenting the root cause? Options: Weekly, Monthly, Quarterly, Rarely, Never
      • Can you share a recent instance where a lead or generator issue changed a clinical decision or scheduling? What happened and how long has this pattern been occurring?
      • How do these reliability issues typically present (select all that apply)? Options: Lead fracture, Insulation failure, Battery depletion/shorter longevity than expected, Inappropriate therapy/shock, Connector/electronics problems, Recall-related disruptions, Other
      • What operational burdens do these events create (OR time, readmissions, clinic workload, reputational risk)? If possible, quantify the impact.
      • Who on your team owns troubleshooting and post-implant escalation when a device issue arises? Options: Field clinical engineer (FCE), Implanting physician, Device clinic staff, Biomedical/clinical engineering, Combined team, Other

      When MRI Demand Forces Tough Choices

      • Have you had to delay or deny MRIs because a patient’s implanted device wasn’t compatible—and what was the downstream cost to the patient or care plan? Options: Frequently, Occasionally, Rarely, Never
      • Approximately what percentage of your implant population will need an MRI within 3–5 years of implantation? Options: <10%, 10–24%, 25–49%, 50–74%, 75%+
      • Describe a case where MRI compatibility (or lack of it) altered device choice or patient management.
      • Which MRI-related requirements most drive your device choice? Options: Full-body MRI-conditional labeling, Head/brain MRI conditional only, Clear manufacturer MRI protocols, Easy radiology sign-off/workflow, Minimal additional monitoring during MRI, Other
      • What process or policy obstacles inside your hospital make MRI-conditional adoption harder?

      Is Remote Monitoring Adding Value — or Sapping Your Team?

      • If your remote monitoring system disappeared tomorrow, how badly would your clinic and patients be affected? Options: Critical disruption, Major inconvenience, Manageable with strain, Minimal impact
      • Which remote monitoring platform(s) do you currently use? Options: Vendor A, Vendor B, Vendor C, Multiple vendors, In-house platform, None / manual processes, Other
      • Approximately how many actionable alerts does your clinic handle per week? Options: <10, 10–49, 50–199, 200–499, 500+
      • Who triages alerts and what is the average time-to-action (if known)? Options: Clinic nurses/coordinators, Electrophysiologists, Field clinical engineers, Automated triage + clinician review, Other
      • Describe the biggest inefficiency in your alert workflow and how that inefficiency affects staff morale or patient care.

      Who Really Decides — and How Fast?

      • If procurement were asked to name the single biggest non-clinical barrier to adopting a new device standard, what would they say? Options: Price/volume discounts, Service/support expectations, Regulatory/registration workload, Vendor consolidation concerns, Clinical evidence gaps, Other
      • What does your VA (value analysis) committee require for device evaluation? Options: Clinical registry data, Real-world reliability evidence, Economic/cost-per-case analysis, Pilot/proof-of-concept, Service level agreements (SLA), Training & field CE plan, Other
      • What is your typical timeline from initial clinical interest to VA committee decision for a new device? Options: <1 month, 1–3 months, 3–6 months, 6–12 months, >12 months
      • Who are the non-negotiable approvers for device adoption and what does each approver care most about?
      • Looking back, what procurement decisions felt rushed or stalled—and what single lesson should be applied next time?

      Imagine a Clinic That Runs With Less Friction

      • What would it feel like if device-related work in your clinic became invisible—no surprises, fewer calls, and predictable scheduling? Options: Transformative, Greatly improved, Somewhat better, Not realistic
      • Which measurable outcomes would convince you a device change was successful? Options: Fewer revisions per 100 implants, Reduced remote monitoring alert volume, Increased battery longevity (years), Shorter procedure times, Fewer MRI-related delays, Lower overall cost per patient
      • Tell us about one patient outcome or clinical confidence moment you’d want to see reproduced consistently.
      • Which emotional shifts among your team would most signal success (e.g., less anxiety, more trust, regained time)? Options: Lower staff stress, Higher physician confidence, Nurses feel empowered, Better patient trust/satisfaction, Other
      • If you had to accept one compromise to get those gains (higher upfront price, limited device range initially, longer rollout), what would you tolerate? Options: Slightly higher price, Smaller device range initially, Longer implementation timeline, Pilot only in select clinics, Other

      Walk Me Through a Real Implant Day — What Could Change?

      • What single moment during implant day most determines whether the procedure feels smooth or stressful? Options: Device/programming issues, Field CE availability, OR scheduling conflicts, Lead handling difficulties, Unexpected patient anatomy/clinical complexity
      • What level of field clinical engineering coverage do you currently expect for implants? Options: Dedicated in-room support for every case, On-call support available, Scheduled coverage for complex cases only, No field CE support
      • Which integrations are already live at your center (EMR, remote monitoring, scheduling, inventory/registrations)? Options: EMR integration, Remote monitoring integration, OR scheduling integration, Inventory tracking/registrations, None of the above
      • What just-in-time training or supports would make your implant teams more confident during rollout?
      • Which acceptance criteria must be met post-implant to call a pilot successful (clinical, connectivity, registration, patient experience)? Options: Successful device registration, Stable remote-monitoring connectivity, No device-related re-interventions within X months, Clinician satisfaction survey scores, Patient onboarding completion

      What Small Pilot Would Convince You to Change?

      • If we proposed a limited pilot that minimized your risk, what single outcome would make you expand the relationship? Options: Improved lead reliability metrics, Reduced remote-monitoring workload, Clear MRI compatibility gains, Better field CE responsiveness, Cost neutrality or savings
      • What pilot size and scope would feel manageable to your team? Options: Single-operator pilot (10–25 cases), Single-site pilot (25–100 cases), Multi-site pilot (100–300 cases), Unsure—need guidance
      • Which operational owners need to be identified up front to own pilot success? Options: Implanting physician lead, Device clinic lead, Procurement/vendor manager, Field CE liaison, Clinical engineering/biomed, IT/EMR lead, Other
      • What commercial, regulatory, or legal details would block a pilot unless addressed?
      • Realistically, when could you start a low-risk pilot if logistics were aligned? Options: Immediately, Within 1–3 months, 3–6 months, 6–12 months, Unsure
    2. Current State Mapping

      Document implant volumes, historical lead/generator issues, MRI demand, remote monitoring burden, and field clinical engineering coverage.

      Current State

      Quick Snapshot: Tell Us About Your Program

      • Roughly how many cardiac device implants does your center perform per year? Options: < 100, 100–249, 250–499, 500–999, 1,000+, Unsure / fluctuates
      • What is the typical mix of procedures in your program? Options: Pacemaker (PPM), ICD, CRT, Insertable Cardiac Monitor (ICM), Lead revisions/extractions
      • Who is the primary clinical decision-maker for device selection in your program? Options: EP Section Chief, Device Clinic Director, Cardiac Surgeon, Hospital Procurement/Vendor Management, Value Analysis Committee, Shared decision
      • Which manufacturers are currently implanted most often at your center? Options: Manufacturer A, Manufacturer B, Manufacturer C, Manufacturer D, Other, Prefer not to say
      • Briefly describe how your implant program is organized (roles, clinic vs lab split, FTEs).
      • How many days per week do you run implant/EP lab cases? Options: 1–2 days, 3 days, 4 days, 5+ days, Irregular schedule

      When Reliability Becomes Personal: How Often Does a Device Problem Interrupt Care?

      • How frequently do lead or generator issues meaningfully disrupt a planned implant or follow-up in your center? Options: Weekly, Monthly, Quarterly, Rarely (yearly), Almost never
      • Tell us about a recent reliability incident that had clinical or operational consequences—what happened and who was affected?
      • When a lead or generator problem occurs, how long does it usually take to reach a resolution (temporary workaround or definitive fix)? Options: Same day, 1–3 days, 4–7 days, > 1 week, Varies widely
      • Which of these impacts have you seen from device reliability problems? Options: Procedure delays/cancellations, Extended OR time, Readmissions, Increased clinic workload, Patient anxiety/complaints, Value analysis escalations
      • Approximately what percentage of your device-related corrective actions are vendor-managed versus internally managed? Options: Almost all vendor-managed, Mostly vendor-managed, Even split, Mostly internal, Almost all internal, Unsure

      MRI Demand Is Rising — Are You Ready or Just Coping?

      • How often does a patient's anticipated need for MRI change which device or lead you would choose? Options: Often (majority of cases), Regularly (many cases), Sometimes, Rarely, Never / not considered
      • What percentage of implants you perform are for patients who currently have or are likely to need MRI in the future? Options: > 75%, 50–75%, 25–49%, < 25%, Unknown
      • Describe a case where MRI requirements forced a change in device or timing of care.
      • Which MRI-related constraints cause the most friction for your team? Options: Limited MRI slots, Radiology policies, Device compatibility uncertainties, Patient logistics (implants vs scans), Formulary limitations, Other
      • Do you have formal hospital policies or procurement preferences that prioritize MRI-conditional devices? Options: Yes—required, Yes—preferred but optional, No policy, Under discussion

      Is Remote Monitoring Helping or Hiddenly Harming Your Clinic?

      • Are remote monitoring alerts a net time-saver or a growing administrative burden for your clinic? Options: Net time-saver, Neutral, Growing burden, Unsure
      • How many monitored patients does one full-time clinical staff member manage on average in your program? Options: < 250, 250–499, 500–999, 1,000+, We don't track by FTE
      • Which remote monitoring platforms are in active use at your center? Options: Platform A, Platform B, Platform C, Multiple vendor platforms, In-house/Custom, None
      • What types of remote alerts generate the most false positives or unnecessary work? Options: Noise/artifact, Lead impedance changes, Battery elective replacement, Non-actionable arrhythmia detections, Connectivity drops, Other
      • Describe your current triage/escalation workflow for RM alerts and where it breaks down most often.
      • If you could change one thing about your remote monitoring setup overnight, what would it be?

      Field Clinical Engineering: Heroic Work or Systemic Risk?

      • How reliably is a vendor field clinical engineer available for implants that need their presence? Options: Always available on-site, Usually available, Sometimes available, Rarely available, Never relied on
      • How quickly does your field CE typically respond when called to support a case? Options: < 15 minutes, 15–30 minutes, 30–60 minutes, > 60 minutes, Not applicable
      • What percentage of your implants are performed with vendor CE physically present? Options: 100%, 75–99%, 50–74%, 25–49%, < 25%, None
      • Share an example where CE presence materially changed an implant outcome (positive or negative).
      • Which CE-related issues create the most anxiety for clinicians? Options: Lack of device expertise, Delays in arrival, Inconsistent troubleshooting, Poor communication, Credentialing/access issues, Other
      • How would you rate vendor CE performance over the last 12 months? Options: Excellent, Good, Fair, Poor, Very poor, Inconsistent

      Inventory, Scheduling, and Procurement — Where Bottlenecks Live

      • Is your implant inventory managed consignment, stockroom purchase, or hybrid? Options: Consignment, Purchase/stockroom, Hybrid, Centralized hospital supply, Other
      • How often do you experience stockouts or missing kits that delay scheduled cases? Options: Weekly, Monthly, Quarterly, Rarely, Never
      • What is the typical lead time for special-order devices or uncommon lead models? Options: Same day, 1–3 days, 4–7 days, > 1 week, Variable/unknown
      • Describe how scheduling, inventory, and procurement interact when there is a device shortage.
      • How much pressure does procurement put on the clinical team to standardize on fewer vendors for volume discounts? Options: High pressure, Moderate pressure, Low pressure, None, Not involved in these decisions
      • Would your center consider a formal volume commitment or consignment model if it reduced stockouts and improved terms? Options: Yes—likely, Maybe—needs review, Unlikely, No

      Data, Integration, and the Signals You Actually Use

      • Do your EMR and remote monitoring platform exchange device/alert data automatically today? Options: Fully integrated, Partially integrated, Manual uploads only, Not integrated, Planning integration
      • Can you reliably track device serials/UDI and registration for regulatory purposes from your systems? Options: Yes—systematically, Yes—but manual effort, No—fragmented, Not tracked
      • Which KPIs are most important to your team when evaluating device performance and vendor accountability? Options: Lead failure rate, Generator longevity, MRI compatibility rate, RM alert burden, Time-to-resolution for issues, Cost per implant
      • Where are your biggest blind spots in device performance data (what you wish you could measure but can’t)?
      • How often do you produce data summaries for your Value Analysis committee about device performance? Options: Monthly, Quarterly, Annually, Ad-hoc when issues arise, Never
      • Who owns follow-up on device performance analytics internally? Options: Device clinic leadership, Quality/Outcomes team, EP Section Chief, Vendor liaison, No clear owner

      If Everything Was Different: What Would Success Actually Feel Like?

      • Imagine a year from now your device program is running ideally—what three measurable changes would tell you we got it right? Options: Fewer device-related OR delays, Reduced RM workload per FTE, Lower lead failure rate, Improved patient satisfaction, Shorter time-to-resolution, Better VA committee outcomes
      • Which outcome would your clinical team defend as the non-negotiable improvement to consider a vendor switch or new partnership? Options: Reliability metrics, Field CE responsiveness, RM burden reduction, Better MRI compatibility, Cost savings, Improved data integration
      • What internal obstacles would most likely block meaningful change even if a vendor delivered on promises? Options: Procurement resistance, Clinical skepticism, IT/integration delays, Lack of budget, Operational inertia, Other
      • Who are the individuals or groups that we would need to convince to pilot a different device or support model? Options: EP Section Chief, Device Clinic Director, Value Analysis Committee, Procurement/Materials Management, Radiology/MRI leadership, Nursing/OR leadership
      • If you were open to a limited pilot, what would a minimally viable pilot look like (scope, duration, metrics)?
      • How soon could you realistically start a pilot if leadership agreed? Options: Within 30 days, 1–3 months, 3–6 months, 6+ months, Depends on procurement
  2. Customer Discovery

    Clarify desired clinical and operational outcomes, measurable success signals, risks, and decision criteria (reliability, MRI, remote monitoring, longevity).

    Discovery Questions

    Getting Oriented Together

    • Please tell us your name, role, and one sentence about your responsibility for the device program.
    • Which title best describes you today? Options: Electrophysiology section chief, Device clinic director/manager, Cardiac surgeon, Cardiology service line administrator, Nurse practitioner / advanced practice provider, Other
    • How many cardiac device implants does your center perform per year (all device types combined)? Options: <50, 50–199, 200–499, 500–999, 1000+
    • Which device categories are you actively implanting today? (select all that apply) Options: Pacemakers, ICDs / S-ICDs, CRT-P/CRT-D, Insertable cardiac monitors (ICMs), Leadless pacemakers, Other
    • Roughly what percentage of your new implants require MRI-conditional systems today? Options: 0–10%, 11–25%, 26–50%, 51–75%, 76–100%
    • How would you describe your current relationship with your primary device vendors? Options: Very collaborative, Generally positive, Transactional, Tense / needs improvement, We frequently evaluate new vendors

    If Reliability Isn’t Your Biggest Fear, What Is?

    • When a lead or generator fails at your center, what typically happens next—and who bears the most clinical and operational burden?
    • How many clinically significant lead/generator failures or urgent explants have you managed in the last 12 months? Options: 0, 1–2, 3–5, 6–10, 10+
    • Tell us about a specific failure or recall that changed how your team thinks about device selection—what stuck with you?
    • Which consequences of device problems are most painful for your organization? (select up to 3) Options: Patient harm or readmission, OR scheduling disruption, Increased clinic workload, Regulatory reporting burden, Reputational risk, Cost of replacement procedures
    • How does the team feel emotionally after handling a preventable device complication—angry, exhausted, more cautious, or something else?
    • How long do quality- or reliability-related concerns linger in committee discussions or vendor evaluations here? Options: They dominate discussions for months, A few meetings, Briefly, then move on, Rarely discussed

    Where Does MRI Access Break the Patient Pathway?

    • How often do you have a case where MRI access is delayed or denied because of the implanted device? Options: Never, Rarely, Occasionally, Often, Very frequently
    • Describe a recent example where MRI compatibility—or lack of it—changed the clinical plan for a patient.
    • What percent of your implanted population do you expect will need at least one MRI within 5 years of implant? Options: <10%, 10–25%, 26–50%, 51–75%, 76–100%
    • Which MRI-conditional features would make your team comfortable scheduling MRIs without lengthy approvals? (select all that apply) Options: Full-body conditional labeling, Clear MRI protocols and scan modes, Vendor-provided MRI safety training for radiology, On-call field engineer support during MRI, Automated documentation for MRI approval
    • What steps in your MRI-approval process create the most delays or risk—documentation, radiology comfort, scheduling, or something else?

    Is Remote Monitoring Helping or Hijacking Your Clinic?

    • Do your clinicians feel that remote monitoring reduces risk or creates more administrative work? Options: Mostly reduces risk, Balanced (both), Mostly increases workload, Unsure
    • How many remote-monitoring transmissions or alerts does your device clinic triage per week? Options: <50, 50–199, 200–499, 500–999, 1000+
    • Of those alerts, roughly what percentage do you consider clinically actionable? Options: <5%, 5–15%, 16–30%, 31–50%, 51%+
    • What part of remote monitoring costs you the most time—triage, documentation, patient calls, or follow-up scheduling? Options: Triage/interpretation, Documentation, Patient outreach, Scheduling follow-ups, Technical troubleshooting
    • If you could redesign how remote-monitoring alerts arrive and get handled, what would you change first?
    • How does remote-monitoring workload affect staff morale and turnover in your clinic?

    What Would True Field Support Feel Like?

    • When an implant is scheduled, what does an ideal on-site field clinical engineering presence look like to you?
    • Which current model best matches your field CE coverage today? Options: Dedicated onsite CE for every case, On-call CE with variable attendance, Remote CE support only, Mixed model depending on procedure complexity
    • Share a time when field CE presence changed the procedural outcome or clinician confidence—what happened and why did it matter?
    • What are the three biggest gaps you see in vendor field support that you’d want fixed?
    • For urgent intra-procedural device issues, what maximum response time would be acceptable to you? Options: Immediate/onsite, ≤30 minutes, 30–60 minutes, Same day, Next business day

    If You Could Rebuild Device Selection, What Would You Change?

    • What single assumption about device selection here would you challenge if you could—price, reliability data, vendor support, or something else?
    • Which criteria does your value analysis committee prioritize most when choosing a primary device vendor? (select up to 4) Options: Clinical reliability/data, Price/total cost, MRI compatibility, Remote monitoring platform, Field CE support, Battery longevity, Regulatory track record
    • How long does it typically take from initial clinical interest to committee decision on device selection? Options: <1 month, 1–3 months, 3–6 months, 6–12 months, >12 months
    • Describe a past vendor change or standardization effort—what went well and what surprised you?
    • What evidence or materials would make your committee feel confident to change or expand device selection? Options: Long-term reliability data, Independent registry results, Operational impact analysis, On-site trial/pilot, Vendor references, Cost-benefit model

    What Does a Clinically Meaningful 'Win' Look Like?

    • If we worked together and delivered an ideal outcome, what would be different in your clinic in 12 months?
    • Which measurable signals would tell you that a device or program is succeeding? (select all that apply) Options: Lower explant/revision rates, Fewer MRI scheduling delays, Reduced RM alert burden, Improved patient satisfaction scores, Lower total cost per patient, Faster procedure times
    • What thresholds would you consider acceptable for those signals (e.g., revision rate reduction %, RM alert reduction %)?
    • Who will be accountable for tracking these KPIs internally, and how are they currently reported?
    • How should we validate outcomes together—site audits, shared dashboards, or a formal VA committee report? Options: Shared dashboard with access, Quarterly joint review, Formal VA committee presentation, Independent audit, Other

    Small Changes, Big Impact — What’s One Step?

    • What’s the smallest, lowest-risk pilot you would consider to test a new device and support model? Options: Limited device mix for select implant types, Single-operator pilot, Time-limited volume pilot (e.g., 50 cases), Remote-monitoring platform trial, Other
    • How soon could you realistically run that pilot if stakeholders agreed? Options: Immediately, Within 1–3 months, 3–6 months, 6–12 months, Longer
    • Which stakeholders would we need to engage to green-light a pilot (clinical, procurement, IT, radiology, VA committee)? Select all that apply. Options: EP physicians, Device clinic director, Cardiology admin/service line, Procurement/value analysis, Radiology/MRI leadership, IT/EMR team, Risk/compliance
    • What practical barriers would most likely stop a pilot—scheduling, inventory, training, regulatory signoff, or culture? Options: Scheduling, Inventory, Training, Regulatory/VA approval, Clinician buy-in, Other
    • If we offered clinician training plus on-site CE coverage for the first 20 cases, would that meaningfully reduce your perceived risk? Options: Yes, Maybe, No

    Decision and Timing — What Are the Hidden Hurdles?

    • What parts of your procurement or VA process tend to elongate timelines unexpectedly?
    • Which timing window is the most realistic for a full vendor evaluation and committee decision at your institution? Options: 1–2 months, 3–6 months, 6–9 months, 9–12 months, >12 months
    • What budget or contracting constraints usually influence device adoption decisions here?
    • Are there regulatory or registry obligations (e.g., state reporting, VA documentation) that we should prepare to support? Please list.
    • Who are the informal influencers that can speed or stall decisions (e.g., a senior EP, OR manager, radiology director)?

    Commitment to Follow-up — How Should We Stay Connected?

    • Which communication channel feels most natural for regular updates during evaluation and pilot phases? Options: Email summaries, Shared dashboard, Monthly video check-ins, On-site meetings, Secure messaging/portal
    • How often would you like structured progress updates (status, KPIs, issues) during a pilot or roll-out? Options: Weekly, Biweekly, Monthly, Quarterly, On-demand as issues arise
    • Who should be invited to those touchpoints to make them effective? Options: EP leadership, Device clinic manager, Procurement rep, Radiology lead, Field CE lead, IT/EMR rep
    • What specific materials or evidence would you like us to provide before any committee presentation (e.g., reliability dossier, cost model, pilot protocol)? Select all that apply. Options: Reliability and longevity data, Clinical case studies, Operational impact analysis, Pilot protocol and metrics, References from peer hospitals, Regulatory documentation
    • Before we finish, what’s one lingering concern we haven’t covered that would prevent you from moving forward?
  3. Solution Experience

    Walk through realistic implant and clinic scenarios showing how device reliability, MRI-conditional design, remote monitoring, and field engineering change outcomes.

    Experience Meetings

    • Experience Preparation & Current-State Confirmation
    • Scenario Walkthrough — Implant Reliability & Re-intervention
    • Scenario Walkthrough — MRI-Conditional Pathway
    • Scenario Walkthrough — Remote Monitoring & Clinic Capacity
    • Combined End-to-End Experience with Field Clinical Engineering
    • Remote monitoring lead to provide alert type breakdown (daily), current triage time, and % resulting in clinical action.
    • Obtain explicit validation from clinical and administrative stakeholders that the modeled future state matches their expectations.
    • Agree on pilot metrics and decision thresholds for moving forward.
    • Prepare a site-specific cost model showing savings per avoided re-intervention using provided OR and staff cost numbers.
    • Identify 1–2 upcoming implants to enroll in a reliability-focused pilot and secure calendar hold for observation.
    • Field CE to draft a checklist of intra-op verification steps that change when using our device to reduce procedural time.
    • Recap: MRI-related Current State & Consequence
    • Demonstrate a measurable reduction in MRI denials/delays when using MRI-conditional devices combined with an agreed workflow.
    • Obtain radiology and device clinic validation that the future state is operationally acceptable.
    • Define pilot scope and KPI collection for MRI pathway validation.
    • Radiology to supply average scheduling lead-times and count of MRI requests for device patients over the last 12 months.
    • Draft the MRI authorization checklist and MR-safety packet that field CE and radiology will use during the pilot.
    • Schedule one end-to-end observed MRI case with participating radiology and device clinic staff.
    • Recap: Remote Monitoring Current State
    • Prove with site data that a revised remote monitoring workflow reduces clinic FTE burden and improves clinically relevant response times.
    • Agree on alert thresholds, escalation paths, and measurable SLAs for the pilot.
    • Define pilot cohort and required data feeds for evaluation.
    • Introductions & Objectives
    • Create a proposed triage matrix showing which alerts are auto-escalated, filtered, or routed to field CE.
    • Enroll initial cohort of 25–50 patients for a 3-month pilot and set up dashboards for monitoring key metrics.
    • One-sentence Future State Review
    • Validate the integrated future state and confirm it meets clinical, operational, and VA committee expectations.
    • Define a clear pilot plan with owners, timeline, and KPI dashboard that will prove the end-to-end outcomes.
    • Secure stakeholder commitment to observed implants and shared data collection during the pilot.
    • Finalize pilot scope document with responsibilities for device clinic, radiology, field CE, and supply chain and circulate for sign-off.
    • Schedule observation dates for at least two implants where field CE will document time-stamps for procedural steps and interventions.
    • Set up an executive dashboard that will report the agreed KPIs weekly during the pilot and name the dashboard owner.
    • Produce and lock a one-sentence current state describing where workflows break and who is affected.
    • Quantify the operational and financial consequences with site-specific numbers.
    • Agree on a one-sentence future state and 3–5 measurable success signals to prove during scenarios.
    • Assign pre-work owners and data extracts required for scenario walkthroughs.
    • Device clinic to provide last 12 months: implant volumes by device type, lead revision count, and reoperation reasons.
    • Radiology/IM to provide MRI demand numbers for patients with implanted devices and historical MRI denials/delays.
    • Remote monitoring lead to export alert volumes, time-to-triage, and staff FTE burden for the last 6 months.
    • Identify 2–3 representative patient cases (one urgent, one elective, one complex) for scenario use.
    • One-sentence Recap of Current State & Consequence
    • Prove with site data that improved device reliability reduces re-interventions and quantify savings.
    • Present Representative Failure Scenario
    • Patient Journey Scenario
    • Explicit Current State (one sentence)
    • Representative Alert Case Walkthrough
    • End-to-End Patient Journey Walkthrough
    • Proof — Triage & Workflow Changes
    • Quantify Consequences
    • Proof — MRI-Conditional Device Path
    • Diagnosis — Where It Broke
    • Field CE Role Play
    • Tie Back to Clinic Pain
    • Proof — Device/Process Change & Measured Impact
    • Define Future State (one sentence)
    • Proof — Combined KPI Impact
    • Operational Impact Mapping
    • Validation Questions & Acceptance Criteria
    • Success Signals & Acceptance Criteria
    • Tie Back — How This Eliminates the Pain You Stated
    • Validation — Agree Alert Thresholds & Escalation Paths
    • Validation & Decision Criteria
    • Validation — Confirm Acceptance Criteria
    • Pilot Enrollment & Data Sharing
    • Agree Pilot Actions
  4. Solution Scope

    Define devices, lead/generator models, remote monitoring platform, field clinical engineering coverage, training, and measurable acceptance criteria.

    Scope Configuration

    • In-procedure field clinical engineer support
    • Initial device programming at implant
    • Remote monitoring activation and transmitter provisioning
    • Patient education on device care and monitoring
    • Clinician hands-on programming and troubleshooting training
    • On-call technical phone support during implants
    • Post-implant technical consultation and troubleshooting visit
    • Device registration and regulatory tracking
    • MRI-conditional scan preparation and device reprogramming
    • Remote monitoring platform provisioning and account setup
    • Firmware and remote software update deployment
    • Generator or lead replacement technical support during revisions
    • Supply and maintenance of clinic programming hardware

    Scope Questions

    In-procedure field clinical engineer support

    • Do you require a field clinical engineer (FCE) to be present during implants? Options: Yes, No
    • Approximately how many implant procedures per month will require on-site FCE support? Options: 0-5, 6-15, 16-30, 31+
    • Which roles should the FCE directly support at the table? Options: Electrophysiologist, Cardiac Surgeon, Fellow/trainee, Scrub nurse/tech, Device clinic RN, Other
    • What specific FCE responsibilities do you expect (select all that apply)? Options: Device preparation/sterile handling, Initial device programming, Intra-procedural troubleshooting, Supply and inventory management, Documentation in procedure note, Other
    • What hours/coverage model do you require for FCE support? Options: Standard weekday hours, After-hours/overnight, Weekend coverage, On-call with guaranteed response time, Scheduled-only (reserved cases)
    • What acceptance criteria should we use to confirm successful in-procedure support? Options: Procedure completed without device-related delays, Device programming completed within target time, Clinician satisfaction score meets threshold, No post-implant technical corrective actions required, Other

    Initial device programming at implant

    • Should vendor personnel perform the initial device programming at implant? Options: Yes, No, Depends on device type
    • Which programming templates or parameter sets are required? Options: Bradycardia pacing, ICD detection and therapy settings, CRT optimization, MRI-mode settings, Custom institutional protocol
    • Who is the final sign-off authority for device programming? Options: Implanting physician, FCE, Device clinic director, Other
    • Do you require the programming to be recorded into your EMR intra-op? Options: Yes - automatic integration, Yes - manual entry by vendor/FCE, No
    • Is there a target timeframe for completing initial programming before patient leaves PACU/OR? Options: Before leaving OR, Within 2 hours post-op, Within 24 hours, Custom
    • Please list any institution-specific programming protocols or contraindications we should follow.

    Remote monitoring activation and transmitter provisioning

    • Do you want the vendor to activate remote monitoring and provision transmitters at discharge? Options: Yes, No, Partial (vendor provisions, hospital enrolls)
    • How many new patients per month do you expect to enroll in remote monitoring? Options: 0-10, 11-30, 31-75, 76+
    • Which transmitter/mobile platforms do you intend to use? Options: Home transmitter, Mobile app (patient smartphone), Clinic-based transmitter, Third-party/enterprise platform, Other
    • Who will be responsible for patient consent and enrollment workflows? Options: Vendor, Hospital device clinic, Shared responsibility, Other
    • Do you require transmitter shipping, inventory management, and replacements handled by vendor? Options: Yes - full service, Yes - parts only, No - hospital manages
    • What is an acceptable timeframe for first successful transmission post-implant? Options: Within 24 hours, Within 72 hours, Within 7 days, Custom

    Patient education on device care and monitoring

    • Do you want vendor-delivered patient education (materials or teaching) as part of the offering? Options: Yes, No, Supplemental to hospital education
    • Which education formats do you prefer for patients? Options: Printed handouts, In-person teaching at discharge, Short instructional videos, Online patient portal content, Smartphone app guidance
    • Do you require materials in languages other than English or translation support? Options: Yes - specific languages, No
    • When should education be delivered? Options: Pre-op/consent visit, Day of discharge, First clinic follow-up, Multi-touch (pre-op + discharge + follow-up)
    • Who signs off that the patient understands device care and monitoring responsibilities? Options: Discharging nurse, Vendor educator, Implanting physician, Patient acknowledgment only
    • What acceptance criteria indicate successful patient education (e.g., enrollment confirmation, comprehension quiz, return demonstration)? Options: Confirmed remote monitoring enrollment, Patient can demonstrate device/transmitter use, Documented comprehension checklist, Other

    Clinician hands-on programming and troubleshooting training

    • Do you require hands-on programming and troubleshooting training for clinicians? Options: Yes, No, Limited to key staff
    • How many clinicians (physicians/NPs/PAs/technicians) should be trained initially? Options: 1-5, 6-15, 16-30, 31+
    • Which training modalities are preferred? Options: On-site workshop, Simulation lab, Remote interactive session, Recorded e-learning modules, Blended approach
    • Which topics must be included (select all that apply)? Options: Device programming basics, Advanced ICD/CRT programming, MRI-mode management, Troubleshooting intra-op and clinic, Remote monitoring platform use
    • Do you require competency assessment or certification after training? Options: Yes - formal assessment, Yes - checklist verification, No
    • Are there scheduling constraints or preferred dates/times for training sessions?

    On-call technical phone support during implants

    • Do you require dedicated on-call technical phone support for implants? Options: Yes, No
    • What coverage hours are needed for phone support? Options: Business hours, Extended hours (early/late), 24/7 on-call, Case-by-case scheduling
    • What is your target response time for phone support during an active implant? Options: <5 minutes, <15 minutes, <30 minutes, Within 1 hour
    • Who is authorized to escalate calls (e.g., to on-site FCE or engineering)? Options: Implanting physician, OR charge nurse, FCE on-site, Other
    • Do you require call documentation and a post-call summary logged into EMR or vendor portal? Options: Yes, No
    • Are there specific clinical engineers or vendor contacts you prefer for escalation?

    Post-implant technical consultation and troubleshooting visit

    • Do you want vendor-led post-implant technical consultation visits? Options: Yes - routine follow-up, Yes - on-request only, No
    • Preferred visit type? Options: On-site clinic visit, Remote video consult, Phone consult, Hybrid
    • Typical timeframe for scheduling a post-implant troubleshooting visit? Options: Within 24 hours, Within 72 hours, Within 7 days, Custom scheduling
    • Which actions should be within scope during the visit? Options: Device diagnostics only, Reprogramming/parameter changes, Hardware inspection/supply replacement, Referral to surgical team
    • What acceptance criteria define a successful troubleshooting visit? Options: Issue resolved without revision, Action plan documented and scheduled, Clinician satisfaction, Device performance restored to baseline
    • Who should be the primary contact to request post-implant visits? Options: Device clinic director, Implanting physician, OR/ward nurse, Other

    Device registration and regulatory tracking

    • Do you want vendor to handle device registration in hospital or national registries? Options: Yes - vendor handles, No - hospital handles, Shared responsibility
    • Which registries or databases must devices be recorded in? Options: Hospital device registry, State/Provincial registry, National device registry, Manufacturer database, Other
    • Who will supply patient identifiers and consent for registration? Options: Hospital/EMR team, Vendor with hospital-provided data, Patient directly, Other
    • What is your required timeframe for completing registrations post-implant? Options: Same day, Within 48 hours, Within 7 days, Custom
    • Do you require automated adverse event or recall notification workflows tied to registrations? Options: Yes, No
    • Are there local data privacy or consent requirements the vendor must follow for registrations? Options: Yes - specify in follow-up, No

    MRI-conditional scan preparation and device reprogramming

    • Do you expect vendor support for MRI scan preparation and device reprogramming? Options: Yes - pre/post scan reprogramming, Yes - consulting only, No
    • How many MRI events per month do you anticipate requiring vendor support? Options: 0-5, 6-20, 21-50, 51+
    • Will MRIs be performed in-house or at external imaging centers? Options: In-house hospital MRI, External imaging center, Both
    • Who should perform the pre/post-scan device programming at the MRI site? Options: Vendor FCE, Hospital device clinic staff, MRI technologist with vendor remote guidance, Other
    • What documentation and acceptance criteria are required after MRI (e.g., device returned to baseline, report filed)? Options: Post-scan reprogramming documented, Device parameters unchanged from baseline, Clinician sign-off, Other
    • Are there special MRI safety protocols or contraindications at your institution we should follow?

    Remote monitoring platform provisioning and account setup

    • Do you require vendor provisioning of the remote monitoring platform and user accounts? Options: Yes - full provisioning, Yes - basic provisioning, No - hospital IT will provision
    • How many user accounts and role types will be needed initially? Options: 1-5, 6-20, 21-50, 50+
    • Are EMR integrations or single sign-on (SSO) required for user access? Options: Yes - EMR integration, Yes - SSO, Neither
    • What reporting and dashboard capabilities are required (select all that apply)? Options: Alert routing, Volume reports, Individual device diagnostics, Population health metrics, Custom exports
    • Do you require vendor-led training for platform users? Options: Yes - live training, Yes - recorded modules, No
    • Are there security or compliance requirements (e.g., HIPAA, GDPR) that must be met for platform access? Options: Yes - specify in follow-up, No
  5. Mutual Commit

    Finalize commercial terms, service levels, volume commitments, regulatory responsibilities, and VA committee documentation.

    Agreement Modules

    • Master Purchasing Agreement (MPA)
    • Statement of Work (SOW)
    • Service Level Agreement (SLA)
    • Pricing & Volume Commitment Schedule
    • Warranty & Returns Agreement
    • Regulatory & Product Registration Responsibilities
    • Value Analysis (VA) Committee Submission & Approval
    • Data Processing Agreement (DPA) / HIPAA Business Associate Agreement (BAA)
    • Clinical Training & Proctoring Agreement
    • Inventory, Forecasting & Replenishment Plan
    • Ordering, Billing & Payment Terms
    • Third-Party Integration & Connectivity Agreement
    • Acceptance Criteria & Post-Implant Validation
    • Change Order & Scope Management
    • Termination, Transition & Exit Plan
  6. Deployment

    Operationalize rollout with readiness checks, enablement, and outcome validation.

    1. Pre-Deployment Readiness

      Confirm inventory, scheduling for field clinical engineers, EMR and remote-monitoring integrations, patient onboarding, and regulatory registrations.

      Readiness Questions

      Start Here — Your Clinic in One Minute

      • Roughly how many cardiac device implants does your center perform per year? Options: < 50, 50–149, 150–399, 400–799, 800+
      • Which device types do you implant on a regular basis? Options: Pacemaker (PPM), ICD (single/dual), CRT-P / CRT-D, Insertable Cardiac Monitor (ICM), Other
      • Who owns routine device follow-up and remote-monitoring triage in your program today? Options: Device clinic nurses/techs, EP physicians, Field clinical engineers (vendor), Shared model, Outsourced remote-monitoring service, Other
      • Tell us which EMR, scheduling, and device-management systems you rely on (include vendor names and versions if known).
      • How would you rate your team’s bandwidth for onboarding new device models or a new remote-monitoring platform? Options: Plenty of bandwidth, Manageable with planning, Strained—needs extra resources, No capacity without external support
      • What top three outcomes would make a new device or partner feel like a clear win for your center?

      Are You Quietly Tolerating Risk?

      • Which device or lead performance vulnerabilities have you been accepting as 'part of the business' rather than actively solving?
      • In the last 24 months, how many lead or generator advisories, recalls, or device-specific alerts directly affected patients you implanted? Options: None, 1–2, 3–5, 6–10, 11+
      • When those issues occur, where does most of the operational burden fall? Options: Device clinic staff, OR/EP lab team, Radiology/Imaging, Patient and family, Risk & compliance, Finance/billing
      • Give a recent example of a device-related problem (brief story): what happened, who was impacted, and what was the emotional or reputational cost?
      • How long has your team tolerated these risks before deciding to escalate or change practice? Options: Weeks, Months, 1–2 years, Several years, We haven't escalated
      • How worried are you about regulatory or VA committee scrutiny tied to device reliability and post-market issues? Options: Very worried, Somewhat worried, Neutral, Not worried

      Where Does Reliability Actually Cost You?

      • If you tallied staff hours, procedure delays, and avoidable readmissions from device failures, how material is that cost to your program? Options: Minimal, Noticeable, Material but manageable, Significant strain on the program
      • How many actionable remote-monitoring alerts does your clinic receive per week (approx.)? Options: < 25, 25–99, 100–299, 300–699, 700+
      • Who triages those alerts and what’s the average time spent per alert? Options: Nurse/tech (<=5 min), Nurse/tech (6–15 min), EP physician (>15 min), Vendor FCE triage, Mixed model
      • What percentage of your implanted patients are likely to need an MRI at some point within five years? Options: < 10%, 10–25%, 26–40%, 41–60%, 61%+
      • What device performance thresholds would translate to clear savings for you (pick all that apply)? Options: Lead failure rate <0.5% at 5 years, Battery life >=10 years, False alert reduction >=50%, Post-implant complication rate <1%, Fewer clinic visits per patient/year
      • How do device-related costs show up in your budget or KPIs (examples: readmission penalties, OR overtime, nurse FTEs)?

      What Would Perfect Follow-Up Actually Feel Like?

      • Imagine every implanted patient is reliably remotely monitored with minimal false alerts—what changes first in your day-to-day workflow?
      • Which clinical outcomes would make you tell your department this change was worth it (select up to three)? Options: Fewer emergency device-related admissions, Faster detection of clinically significant arrhythmias, Reduced post-implant complications, Improved patient satisfaction, Lower clinic workload
      • What numerical targets would prove success for you within the first 6–12 months (pick one or write your own)? Options: Reduce actionable alerts by 25%, Reduce by 50%, Cut clinic follow-up visits by 20%, Lead failure rate reduction target (specify below), Other—will specify
      • Who on your team needs to feel the clinical benefit first to support broader adoption? Options: EP section chief, Device clinic director, OR/EP lab staff, Radiology/imaging leadership, Finance/operations
      • How would success feel emotionally for your clinicians—less anxiety, more confidence, time relief, or something else?
      • How soon would you expect to see measurable improvement if the right device and support were in place? Options: Within 1 month, 1–3 months, 3–6 months, 6–12 months, Longer

      Who Moves the Needle Here?

      • If you could change one decision-maker’s view today to accelerate vendor standardization, whose would it be and why?
      • Which stakeholders must sign off in a typical device evaluation (select all that apply)? Options: EP section chief, Device clinic director, Value analysis (VA) committee, Procurement/GPO, Radiology/MRI leadership, IT/EMR, Finance
      • How influential is your VA committee in final device selection? Options: Decisive—must approve, Very influential, Advisory only, Minimal role
      • What specific evidence or deliverables does the VA committee want to see (pick all that apply)? Options: Head-to-head clinical data, Cost modeling & TCO, Service-level agreements (FCE coverage), Training plan, Regulatory/registration documentation, Pilot data
      • What procurement constraints or GPO agreements would limit your ability to add a new vendor? Options: Exclusive GPO contract, Preferred vendor tiers, Volume commitments required, Lengthy contract negotiations, No major constraints
      • What has typically blocked change in the past—data gaps, clinician skepticism, logistics, or budget? Please rank the top two. Options: Clinical evidence gap, Physician preference, Operational complexity, Budgetary limits, Regulatory/credentialing hurdles

      Where Integration and Training Tend to Break Down

      • What integration points have caused the biggest headaches when adopting a new device or remote platform?
      • What is your current EMR integration status with remote-monitoring data? Options: No integration, Partial (manual uploads), Bi-directional automated integration, Vendor dashboard only
      • After implant, how often do you experience connectivity or data-loss issues that require technical escalation? Options: Never, Rarely (monthly), Sometimes (weekly), Often (multiple times/week)
      • What training model works best for your team when adopting new devices (choose all that apply)? Options: Hands-on FCE in OR, Simulation sessions, Online modules with assessment, On-site train-the-trainer, Hybrid model
      • How do you currently schedule vendor field clinical engineers (FCEs) for implants and follow-up? Options: Dedicated in-house FCEs, On-call vendor FCEs scheduled per case, No FCE support, Hybrid/rotating model
      • Describe the biggest gap in training or integration that, if fixed, would remove friction for your team.

      If We Partnered, What Would Make You Confident?

      • What is the single most persuasive proof point that would make you shift implant volumes to a new device partner?
      • Which acceptance criteria must be met before you commit to a new device (select up to four)? Options: Clinical reliability data, MRI conditionality confirmed, Remote-monitoring usability & alert specificity, Field CE response time SLA, Battery longevity data, Favorable TCO
      • For each of these performance areas, what numerical threshold would you require? (pick one overall range) Options: Conservative/high bar, Moderate improvement over current, Marginal improvement acceptable with other benefits, No fixed threshold—case by case
      • What commercial or service terms would be deal-enabling for you (choose all that matter)? Options: Volume discounts, Guaranteed FCE coverage hours, Pilot with limited risk, Regulatory support and registration, Training and implementation credits, Data-sharing for VA committee
      • Would you prefer an outcomes-focused pilot (measure clinical impact) or an operational pilot (measure workflow and integration)? Options: Outcomes-focused, Operational-focused, Both combined, Unsure—want to discuss
      • What internal approvals or endorsements would you need to proceed after a successful pilot? Options: VA committee sign-off, EP section chief approval, Procurement contract, IT/EMR sign-off, Finance approval

      Next Steps — The Smallest Pilot That Proves It

      • What would a minimally viable pilot look like to you (number of implants, duration, metrics)? Please propose specifics.
      • Which outcome metrics must improve during that pilot to consider expansion (select up to three)? Options: Actionable alert reduction, Time-to-action on alerts, Fewer device-related readmissions, Improved patient satisfaction, Reduced clinic FTE hours
      • Who should own the pilot internally (role/title) and who is the vendor owner we should coordinate with?
      • What regulatory or VA documentation will you require before starting a pilot? Options: Device IFU and labeling, Regulatory registration plan, VA committee summary, IRB (if required), None beyond standard paperwork
      • What timeline would make a pilot compelling—how quickly do you want to start and when would you expect first results? Options: Start within 2 weeks; results in 1 month, Start in 1 month; results in 3 months, Start in 3 months; results in 6 months, Longer planning cycle
      • What would be the one non-negotiable term or condition we must include to get your buy-in for a pilot?
    2. Deployment Enablement

      Schedule implants, coordinate field CE coverage, run clinician training, and execute remote monitoring onboarding with clear owners and timelines.

    3. Validation Checklist

      Verify device registration, connectivity, initial performance, acceptance criteria, and document any corrective actions required post-implant.

      Validation Questions

      Start: Who You Are and How You Operate

      • Which role best describes you in the implant decision and care pathway? Options: Electrophysiology section chief, Device clinic director/manager, Cardiac surgeon, Cardiology service line administrator, Clinic staff (RN/NP/PA), Procurement/Materials manager, Other
      • Roughly how many cardiac device implants does your program perform per year? Options: <50, 50–199, 200–499, 500–999, 1000+
      • Which device categories are actively implanted at your center today? Options: Pacemakers (PPM), ICDs, CRT-P/CRT-D, Insertable cardiac monitors (ICM), Leadless pacemakers, Other
      • Who typically signs off final device selection for your hospital (title/committee)? Options: EP Section Chief, Device Clinic Director, Cardiology Service Line Director, Value Analysis Committee, Materials/Procurement, Other
      • How would you describe your program’s top three priorities when evaluating a cardiac device vendor? List in order.
      • What is your typical timeline from initial vendor evaluation to a committee decision? Options: <1 month, 1–3 months, 3–6 months, 6–12 months, Undetermined/ad hoc

      If Reliability Were a Promise, Would You Trust It?

      • When was the last time a lead or generator reliability issue made you question your program’s device standard—what happened and why did it stick with you?
      • How frequently do you encounter device-related returns, revisions, or unexplained malfunctions (choose best estimate)? Options: Multiple times per month, Monthly, Quarterly, A few times per year, Rarely/never
      • What specific reliability metrics or thresholds matter most when you evaluate long-term performance (e.g., annual failure rate, lead fracture rate, battery longevity)? Options: Annual failure rate, Lead fracture rate, Battery longevity (years), Pacing threshold stability, Infection rate post-implant, Other
      • Tell us about a particular case where device failure changed clinical workflow, patient outcome, or your level of trust — what were the consequences?
      • What mitigation strategies do you currently use to reduce reliability risk (stocking spares, intra-op testing, specific lead choices, follow-up cadence)? Options: On-site spare inventory, Routine intra-op lead testing/protocols, Preferential lead models, Tighter follow-up schedule, Vendor on-call CE at implant, Other

      Are You Still Trading MRI Access for Device Choice?

      • How often do your device patients require MRI scans within the first five years post-implant—and has that frequency influenced device selection? Options: Very often (>20% of patients), Often (10–20%), Occasionally (5–10%), Rarely (<5%), Unknown
      • Have you had a case where lack of MRI-conditional capability changed clinical management or delayed diagnosis? Please describe.
      • Which MRI-related attributes are non‑negotiable versus nice-to-have (pick non‑negotiables first)? Options: Full-body MRI-conditional labeling, Specific field-strength compatibility (1.5T/3T), Simple reprogramming workflow for MRI, Clear patient labeling and wallet card, Vendor support for MRI protocols
      • How do you currently track MRI conditionality across implanted devices in your EMR or registry? Options: Automated EMR flags, Manual charting, Vendor registry, No formal tracking, Other
      • If a device offered superior reliability but limited MRI labeling, how would you weigh that trade-off on a scale from 'accept' to 'reject'? Options: Accept with conditions, Consider case-by-case, Reject unless MRI covered, Undecided

      Who’s Burning Out Over Remote Monitoring?

      • Do you feel your remote monitoring workload is sustainable for current staffing—why or why not? Options: Sustainable, Manageable with extra effort, Strained but coping, Unsustainable
      • What volume of remote transmissions or actionable events does your clinic handle weekly (approx.)? Options: <50, 50–149, 150–499, 500–999, 1000+
      • How many full-time equivalents (FTEs) are dedicated to RM triage and follow-up in your clinic? Options: 0, 0.1–0.5, 0.5–1.0, 1–3, 3+
      • Which remote monitoring platform capabilities would most reduce clinic burden (prioritize up to three)? Options: Smart alert triage/AI filtering, EMR integration (bidirectional), Patient engagement tools, Automated report generation, Easy credentialing and onboarding
      • Share an example of an alert or workflow that consistently creates unnecessary work—what would you change about it?

      When an Implant Goes Wrong, Who Shows Up?

      • How would you rate the current timeliness and effectiveness of field clinical engineering (CE) support during implants? Options: Excellent (proactive, fast), Good (usually responsive), Inconsistent, Poor (slow or absent)
      • What CE coverage model do you rely on today for implant procedures? Options: Dedicated on-site rep, On-call CE via phone, Hospital-employed CE, Hybrid (on-site for complex cases), No CE support
      • Give an example where CE presence (or absence) materially affected procedure outcome or clinician confidence.
      • What is an acceptable CE response time for intra‑op device trouble or programming needs? Options: Immediate (on-site), <15 minutes, 15–30 minutes, 30–60 minutes, Longer
      • Beyond responsiveness, what CE behaviors or capabilities matter most to your team (technical skill, clinical judgment, sterile-field awareness, communication)? Options: Technical troubleshooting, Clinical workflow support, Effective communication with OR/EP team, Adherence to sterile field, Training and education

      What Would 'Success' Actually Look Like for Your Program?

      • Which measurable outcomes would you use to declare a device/vendor engagement successful at 6 and 24 months? Options: Reduction in revision rate, Fewer emergency device returns, Improved battery longevity vs baseline, Reduced RM workload, Higher clinician satisfaction, Favorable VA committee evaluation
      • How soon would you need to see early signals of success before recommending broader standardization? Options: Immediately (procedural improvements), 3–6 months, 6–12 months, 12+ months
      • Who in your organization signs off on the acceptance criteria—individuals/committees and their priorities? Options: EP Section Chief, Device Clinic Director, Value Analysis Committee, Materials/Procurement, Quality & Safety
      • What specific acceptance criteria would prompt you to escalate corrective actions or terminate a pilot?
      • If long-term monitoring shows an unexpected signal (e.g., early battery drop), how would you expect the vendor to partner with you—what does good look like? Options: Immediate investigation and root-cause, Temporary device swaps, Enhanced clinic support, Regulatory reporting assistance, Other

      What Could Trip Us Up During Implementation?

      • What implementation risk worries you most—logistics, EMR integration, regulatory registration, clinician adoption, or something else? Options: Inventory/supply logistics, EMR/ERP integration, Remote monitoring onboarding, Regulatory/device registration, Clinician training and adoption, Other
      • Are your EMR and device clinic systems ready to accept vendor-sent device data and scheduling workflows? If not, what's missing? Options: Fully ready, Partially ready (API work needed), Needs vendor/IT coordination, Not ready at all
      • Which party should own regulatory device registration and tracking: your hospital, the vendor, or shared responsibility? Options: Hospital owns, Vendor owns, Shared responsibility, Undecided
      • Describe previous implementations (with any vendor) that stalled—what specifically blocked progress?
      • What timeline constraints or procurement windows (VA committee dates, budget cycles) would we need to align with to avoid delays? Options: Next 30 days, 30–90 days, 3–6 months, 6+ months, Dependent on committee schedule

      If You Could Wave a Wand, What Would the Ideal Device Program Include?

      • Which three product attributes would you prioritize if trade-offs were impossible to avoid (pick up to three)? Options: Unmatched lead reliability, Extended battery longevity, Full MRI-conditional labeling, Superior remote monitoring analytics, Seamless EMR integration, Robust CE in-procedure support
      • How do you prefer clinician training and competency to be delivered for new devices—live OR proctoring, hands-on lab, virtual modules, or blended? Options: Live in-OR proctoring, Hands-on simulation lab, Virtual/recorded modules, Blended (combination)
      • What patient onboarding tools would reduce no-shows and improve RM adherence (select all that apply)? Options: Pre-discharge education packets, Digital onboarding app, Automated SMS reminders, In-person RM enrollment by vendor CE, Telephonic patient support
      • Beyond product performance, what ongoing vendor behaviors would make you view this as a strategic long-term partnership? Options: Proactive clinical data sharing, Dedicated account team, Rapid CE response, Joint quality improvement projects, Flexible commercial terms
      • What would make you confident enough to present a vendor to your VA committee as the recommended standard?
  7. Success

    Review outcomes against success signals, confirm long-term monitoring and support, and maintain a shared channel for issues and enhancements.

    Success Reviews

    • Outcomes Review — Clinical & Operational Validation
    • Long‑term Monitoring & Support Plan
    • Issue Triage & Continuous Improvement Governance
    • Regulatory, Documentation & Registry Closeout
    • Cadence Planning — KPI Rhythm & Quarterly Review Setup

    Issues & Enhancements

    • Assign clear owners for ongoing regulatory reporting and EMR reconciliation.
    • Review Open Issues & Severity
    • Create a single, agreed shared channel for ongoing issues and enhancements.
    • Define triage rules and ownership to ensure predictable responses.
    • Put in place a backlog and prioritization method aligned with clinical and VA priorities.
    • Provision the agreed shared channel and invite the triage group.
    • Publish the triage playbook with categories, SLAs, and escalation paths.
    • Create the enhancement intake template and schedule the first prioritization review.
    • Store final validation checklist and training records in the agreed archive location and confirm access rights.
    • Device Registration Status
    • Confirm 100% device and patient registry compliance or have a remediation plan.
    • Welcome & Objectives
    • Ensure documentation is archived and accessible for audits and VA reviews.
    • Run and deliver a registry reconciliation report showing any missing entries and remedial timeline.
    • Assign and document the regulatory reporting owner with contact details.
    • Recap Agreed KPIs & Reporting Format
    • Set a sustainable KPI reporting cadence with dashboard and data ownership.
    • Schedule and staff recurring QBRs with clear agendas and presenters.
    • Agree exception triggers and the mid-cycle escalation process.
    • Provision dashboard access to agreed stakeholders and validate data feeds.
    • Send calendar invites for the next four QBRs with preliminary agendas.
    • Publish the KPI definition document and exception escalation criteria.
    • Confirm which success signals are met and which require action.
    • Quantify operational and clinical consequence of any gaps.
    • Assign owners and deadlines for corrective actions or formal acceptance.
    • Produce a one-page outcome scorecard showing each success signal, baseline, current value, and variance.
    • Assign remediation owners for any unmet signals with due dates and status check cadence.
    • Schedule follow-up validation meeting in X weeks to confirm remediation effectiveness.
    • Current Monitoring Setup Overview
    • Agree formal monitoring responsibilities and SLA targets.
    • Document a clear escalation and case management workflow with owners.
    • Ensure training and onboarding plans exist to sustain monitoring quality.
    • Publish a Monitoring RACI with names, contact methods, and SLA thresholds.
    • Update or create the clinic's SOP for alert triage and vendor escalation.
    • Schedule initial cross-training session for new monitoring staff and identify refresher cadence.
    • Define Quarterly Review Agenda & Participants
    • Alerting, Thresholds & Routing
    • Select & Configure Shared Channel
    • One-sentence Current State Recap
    • EMR & Device ID Reconciliation
    • Success-Signal Metrics Review
    • Post‑Market Surveillance & Event Reporting Workflow
    • Dashboard Data Sources & Access
    • Triage Process & SLAs
    • Field CE Coverage & SLA Alignment
    • Baseline vs Post-Deployment Comparison
    • Exception Process & Mid‑Quarter Escalation
    • Documentation Archive & Access
    • Escalation & Case Management Workflow
    • Enhancement Backlog & Prioritization Criteria
    • Schedule First Four QBRs & Assign Presenters
    • Gap Analysis & Root Cause Discussion
    • VA Committee Documentation Flow
    • Patient & Clinician Training Sustainment
    • Assign Ongoing Regulatory Owners
    • Decision & Next Steps
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.